143 related articles for article (PubMed ID: 12237057)
1. Clinical practice of glycerol preserved allograft skin coverage.
Blome-Eberwein S; Jester A; Kuentscher M; Raff T; Germann G; Pelzer M
Burns; 2002 Oct; 28 Suppl 1():S10-12. PubMed ID: 12237057
[TBL] [Abstract][Full Text] [Related]
2. The use of glycerol-preserved allografts in the Beverwijk Burn Centre: a retrospective study.
Vloemans AF; Schreinemachers MC; Middelkoop E; Kreis RW
Burns; 2002 Oct; 28 Suppl 1():S2-9. PubMed ID: 12237056
[TBL] [Abstract][Full Text] [Related]
3. A historical appraisal of the use of cryopreserved and glycerol-preserved allograft skin in the treatment of partial thickness burns.
Vloemans AF; Middelkoop E; Kreis RW
Burns; 2002 Oct; 28 Suppl 1():S16-20. PubMed ID: 12237059
[TBL] [Abstract][Full Text] [Related]
4. The application of glycerol-preserved skin allograft in the treatment of burn injuries: an analysis based on indications.
Khoo TL; Halim AS; Saad AZ; Dorai AA
Burns; 2010 Sep; 36(6):897-904. PubMed ID: 20299154
[TBL] [Abstract][Full Text] [Related]
5. Banking and use of glycerol preserved full-thickness skin allograft harvested from body contouring procedures.
Zidan SM; Eleowa SA
Burns; 2014 Jun; 40(4):641-7. PubMed ID: 24070848
[TBL] [Abstract][Full Text] [Related]
6. Current indications for glycerol-preserved allografts in the treatment of burn injuries.
Druecke D; Steinstraesser L; Homann HH; Steinau HU; Vogt PM
Burns; 2002 Oct; 28 Suppl 1():S26-30. PubMed ID: 12237061
[No Abstract] [Full Text] [Related]
7. Inability to determine tissue health is main indication of allograft use in intermediate extent burns.
Fletcher JL; Cancio LC; Sinha I; Leung KP; Renz EM; Chan RK
Burns; 2015 Dec; 41(8):1862-1867. PubMed ID: 26471053
[TBL] [Abstract][Full Text] [Related]
8. The cost-effectiveness of maintaining an in-house glycerol-preserved skin bank.
Yeo SY; Hamzan MI; Wan Sulaiman WA; Halim AS
Burns; 2022 Mar; 48(2):390-395. PubMed ID: 34670715
[TBL] [Abstract][Full Text] [Related]
9. Postal survey on the use of glycerol-preserved allografts in clinical practice.
Mackie D
Burns; 2002 Oct; 28 Suppl 1():S40-4. PubMed ID: 12237064
[TBL] [Abstract][Full Text] [Related]
10. Clinical application and viability of cryopreserved cadaveric skin allografts in severe burn: a retrospective analysis.
Cleland H; Wasiak J; Dobson H; Paul M; Pratt G; Paul E; Herson M; Akbarzadeh S
Burns; 2014 Feb; 40(1):61-6. PubMed ID: 24018216
[TBL] [Abstract][Full Text] [Related]
11. Utilisation of glycerolised skin allografts in severe burns.
Dhennin Ch; Desbois I; Yassine A; Benissad H; Lignée J
Burns; 2002 Oct; 28 Suppl 1():S21-5. PubMed ID: 12237060
[No Abstract] [Full Text] [Related]
12. The temporary use of allograft for complicated wounds in plastic surgery.
Moerman E; Middelkoop E; Mackie D; Groenevelt F
Burns; 2002 Oct; 28 Suppl 1():S13-15. PubMed ID: 12237058
[TBL] [Abstract][Full Text] [Related]
13. The impact of skin allograft on inpatient outcomes in the treatment of major burns 20-50% total body surface area - A propensity score matched analysis using the nationwide inpatient sample.
Sheckter CC; Li A; Pridgen B; Trickey AW; Karanas Y; Curtin C
Burns; 2019 Feb; 45(1):146-156. PubMed ID: 30527451
[TBL] [Abstract][Full Text] [Related]
14. The use of non-viable glycerol-preserved cadaver skin combined with widely expanded autografts in the treatment of extensive third-degree burns.
Kreis RW; Vloemans AF; Hoekstra MJ; Mackie DP; Hermans RP
J Trauma; 1989 Jan; 29(1):51-4. PubMed ID: 2642973
[TBL] [Abstract][Full Text] [Related]
15. A randomised clinical trial comparing a hydrocolloid-derived dressing and glycerol preserved allograft skin in the management of partial thickness burns.
Vloemans AF; Soesman AM; Suijker M; Kreis RW; Middelkoop E
Burns; 2003 Nov; 29(7):702-10. PubMed ID: 14556729
[TBL] [Abstract][Full Text] [Related]
16. Immunogenicity of glycerol-preserved human cadaver skin in vitro.
Richters CD; Hoekstra MJ; van Baare J; du Pont JS; Kamperdijk EW
J Burn Care Rehabil; 1997; 18(3):228-33. PubMed ID: 9169946
[TBL] [Abstract][Full Text] [Related]
17. Experience and outcomes of micrografting for major paediatric burns.
Rode H; Martinez R; Potgieter D; Adams S; Rogers AD
Burns; 2017 Aug; 43(5):1103-1110. PubMed ID: 28318749
[TBL] [Abstract][Full Text] [Related]
18. Comparing the use of glycerol preserved and cryopreserved allogenic skin for the treatment of severe burns: differences in clinical outcomes and in vitro tissue viability.
Kua EH; Goh CQ; Ting Y; Chua A; Song C
Cell Tissue Bank; 2012 Jun; 13(2):269-79. PubMed ID: 21484230
[TBL] [Abstract][Full Text] [Related]
19. Evolving practice of the Helsinki Skin Bank.
Lindford AJ; Frey I; Vuola J; Koljonen V
Int Wound J; 2010 Aug; 7(4):277-81. PubMed ID: 20492012
[TBL] [Abstract][Full Text] [Related]
20. From skin allograft coverage to allograft-micrograft sandwich method: A retrospective review of severe burn patients who received conjunctive application of cultured epithelial autografts.
Chua AWC; Khoo YC; Truong TTH; Woo E; Tan BK; Chong SJ
Burns; 2018 Aug; 44(5):1302-1307. PubMed ID: 29475746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
